Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Zymo Research erhält CE IVD-Kennzeichnung für Probenentnahmevorrichtungen
  • USA - español
  • India - English
  • Brazil - Português
  • Latin America - español
  • USA - Français

Zymo Research Corp. Logo

News provided by

Zymo Research Corp.

Sep 28, 2020, 07:36 ET

Share this article

Share toX

Share this article

Share toX

Sichere und zuverlässige Probenkonservierung bei Umgebungstemperatur für IVD-Anwendungen 

IRVINE, Kalifornien, 28. September 2020 /PRNewswire/ -- Zymo Research gab bekannt, dass drei seiner DNA/RNA Shield™ Sammelgeräte: 1) DNA/RNA Shield™ Sammelröhrchen mit Tupfer, 2) DNA/RNA Shield™ Speichel-/Sputum-Sammelkit und 3) DNA/RNA Shield™ Fäkal-Sammelröhrchen sind jetzt CE IVD-gekennzeichnet für in-vitro-diagnostische (IVD) Anwendungen. 

Continue Reading
Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices.
Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices.

Die Produktlinie DNA/RNA Shield™ umfasst Geräte zur Probenentnahme, Konservierung und zum Transport von medizinischen Proben, die in der Forschung verwendet werden, und ist nun auch für die in-vitro-Diagnostik (z. B. COVID-19-Tests) erhältlich. Um das CE IVD-Zeichen zu erhalten, sammelten die Wissenschaftler von Zymo Research umfangreiche Leistungsdaten über die Inaktivierung von Proben (Krankheitserreger) und die Konservierung von Nukleinsäuren. Die Ergebnisse bestätigten eine noch nie dagewesene Stabilisierung der Proben (Wochen/Monate) und der DNA (viele Jahre), wenn die Proben bei Umgebungstemperatur gelagert wurden. Da DNA/RNA Shield™ Krankheitserreger, einschließlich SARS-CoV-2, das Virus, das COVID-19 verursacht, sofort inaktiviert, ist der Probentransport für Laborfachleute und Mitarbeiter an vorderster Front viel sicherer.

„Wir standardisieren die Probensammlung in Klinik und Forschung", sagte Dr. Stanislav Forman von Zymo Research Corp. „Diese Technologie bietet ein hohes Maß an Sicherheit für Ersthelfer und Dienstleister gleichermaßen; während Krankheitserreger inaktiviert werden, bleiben die Nukleinsäuresignaturen erhalten. Das CE IVD-Zeichen ermöglicht es uns, viel mehr klinische Labors und Organisationen weltweit zu unterstützen, einschließlich derer, die während der aktuellen Pandemie COVID-19-Tests durchführen."

Das CE-IVD-Zeichen kommt zu einem kritischen Zeitpunkt, da viele Labors und Organisationen Probenentnahmegeräte zur Unterstützung der COVID-19-Testabläufe benötigen. Zymo Research unterstützt mit seinem Produkt DNA/RNA Shield™ bereits groß angelegte weltweite COVID-19-Tests, darunter das Korona-Testzentrum am Stuttgarter Flughafen. Das Testzentrum wird von der CeGaT GmbH, einem Anbieter von genetischer Diagnostik und NGS-Dienstleistungen mit Sitz in Tübingen, Deutschland, betrieben. Für den Test wird das DNA/RNA Shield™ Sammelröhrchen mit Tupfer verwendet, um Nasen-Rachen-Proben von Flughafenpassagieren zu sammeln, die mit einem Echtzeit-Polymerase-Kettenreaktionstest (RT-PCR) auf SARS-CoV-2 virale RNA untersucht werden. Die Testergebnisse liegen am nächsten Tag als Teil der Bemühungen des Staates zur Eindämmung der Ausbreitung von COVID-19 vor.

„Wir verlassen uns bei der akuten SARS-CoV-2-Diagnostik auf Probenentnahmeröhrchen von Zymo Research", sagte Dr. med. Dr. rer. nat. Saskia Biskup, Geschäftsführerin Praxis für Humangenetik Tübingen & CeGaT GmbH. „Wir schätzen die inaktivierenden Funktionen der CE IVD-zertifizierten DNA/RNA Shield™ Lösung, die uns eine sicherere Probenhandhabung ermöglicht und zu einem höheren Durchsatz in unserem Labor führt."

Für weitere Informationen über DNA/RNA Shield™ und Entnahmegeräte besuchen Sie die Website von Zymo Research oder kontaktieren Sie sie per E-Mail unter [email protected].

Informationen zu Zymo Research Corp.

Zymo Research ist ein Unternehmen in Privatbesitz, das der wissenschaftlichen und diagnostischen Gemeinschaft seit 1994 modernste molekularbiologische Werkzeuge zur Verfügung stellt. „The Beauty of Science is to Make Things Simple" ist ihr Motto, das sich in allen ihren Produkten widerspiegelt, von der Epigenetik bis hin zu DNA/RNA-Reinigungstechnologien. Historisch als führend in der Epigenetik anerkannt, überschreitet Zymo Research Grenzen mit neuartigen Lösungen für Probenentnahme, mikrobiologische Messungen, Diagnosegeräte und NGS-Technologien, die qualitativ hochwertig und einfach zu bedienen sind. Folgen Sie Zymo Research auf Facebook, LinkedIn, Twitter, und Instagram.

Fhoto - https://mma.prnewswire.com/media/1281947/DNA_RNA_Shield_Collection_Devices.jpg

Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg

Related Links

http://www.zymoresearch.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Zymo Research Unveils MultiOmiX Workstation with Show-Stopping Launch at ASM Microbe 2025

Zymo Research Unveils MultiOmiX Workstation with Show-Stopping Launch at ASM Microbe 2025

Zymo Research stole the spotlight at the American Society for Microbiology (ASM) Microbe 2025 conference with the official debut of the MultiOmiX...

Zymo Research Offers Reliable Domestic Solutions Amid Offshore Supply Chain Challenges

Zymo Research Offers Reliable Domestic Solutions Amid Offshore Supply Chain Challenges

As research and diagnostic companies grapple with rising prices and persistent backorders from offshore suppliers, Zymo Research is stepping up to...

More Releases From This Source

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.